Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis
Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis. // Fertility and Sterility. – URL: https://www.sciencedirect.com/science/article/pii/S0015028226004784?dgcid=rss_sd_all
Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis. Fertility and Sterility. https://www.sciencedirect.com/science/article/pii/S0015028226004784?dgcid=rss_sd_all
“Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis.” Fertility and Sterility.
@article{article116853,
title = {Weight loss associated with semaglutide use is linked to improved reproductive measures in polyendocrine metabolic ovarian syndrome: a proof-of-concept analysis},
journal = {Fertility and Sterility},
url = {https://www.sciencedirect.com/science/article/pii/S0015028226004784?dgcid=rss_sd_all}
}